Decreasing RPS19 in tumor cells or interrupting the C5AR1-RPS19 interaction reduces RPS19-mediated immunosuppression, impairs tumor growth, and delays the development of tumors in an in vivo assay of breast cancer [60]. The gene discussed is RPS19; the disease is neoplasm.